Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein

Middle East Respiratory Syndrome coronavirus (MERS-CoV) causes severe pulmonary infection, with ∼35 % mortality. Spike glycoprotein (S) of MERS-CoV is a key target for vaccines and therapeutics because S mediates viral entry and membrane-fusion to host cells. Here, four different S subunit proteins,...

Descripción completa

Detalles Bibliográficos
Autores principales: Goo, Junghyun, Jeong, Yuji, Park, Young-Shin, Yang, Eunji, Jung, Dae-Im, Rho, Semi, Park, Uni, Sung, Hyeyeong, Park, Pil-Gu, Choi, Jung-ah, Seo, Sang Hwan, Cho, Nam Hyuck, Lee, Hyeja, Lee, Jae Myun, Kim, Jae-Ouk, Song, Manki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114870/
https://www.ncbi.nlm.nih.gov/pubmed/31945421
http://dx.doi.org/10.1016/j.virusres.2020.197863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114870/
https://www.ncbi.nlm.nih.gov/pubmed/31945421
http://dx.doi.org/10.1016/j.virusres.2020.197863

Ejemplares similares